Email updates

Keep up to date with the latest news and content from Molecular Pain and BioMed Central.

Open Access Short report

CREB activity maintains the survival of cingulate cortical pyramidal neurons in the adult mouse brain

Hushan Ao, Shanelle W Ko and Min Zhuo*

Author Affiliations

Department of Physiology, Faculty of Medicine, University of Toronto Centre for the Study of Pain, 1 King's College Circle, Toronto, Ontario, M5S 1A8, Canada

For all author emails, please log on.

Molecular Pain 2006, 2:15  doi:10.1186/1744-8069-2-15

The electronic version of this article is the complete one and can be found online at: http://www.molecularpain.com/content/2/1/15


Received:23 February 2006
Accepted:26 April 2006
Published:26 April 2006

© 2006 Ao et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Cyclic AMP-responsive element binding protein (CREB) activity is known to contribute to important neuronal functions, such as synaptic plasticity, learning and memory. Using a microelectroporation technique to overexpress dominant negative mutant CREB (mCREB) in the adult mouse brain, we found that overexpression of mCREB in the forebrain cortex induced neuronal degeneration. Our findings suggest that constitutively active CREB phosphorylation is important for the survival of mammalian cells in the brain.

Short report

Neuronal activity helps to form the complex neuronal circuitry that develops throughout life [1-4]. Among many candidate molecules for mediating activity-dependent plasticity, the transcription factor cyclic AMP-responsive element binding protein (CREB) has been widely investigated. Two major functions of CREB that have been particularly well studied are: (1) its role in the maintenance of long-term memory [2,3] and (2) its role as a survival factor for cells and a molecular transducer for various triggering factors for cell death associated with neurological diseases [5-9]. CREB is rapidly activated by phosphorylation of the serine residue 133 [10]. Inhibition of CREB activity impaired behavioral performance in various memory tests across different species, while the overexpression of CREB facilitated long-term memory [2,3]. The overexpression of dominant-negative CREB or genetic deletion of CREB leads to reduced survival of sympathic/cerebellar neurons and progressive neurodegeneration in postnatal forebrains, while the overexpression of CREB supports neuronal survival [5-9].

The anterior cingulate cortex (ACC) is a key forebrain structure and is implicated in several higher brain functions, including attention, conflict monitoring, memory, pain, pleasure and decision-making [11,12]. Dysfunction of ACC neurons may contribute to the cognitive deficits in mental disorders, including positive and negative symptoms of schizophrenia [13]. CREB activity is increased in ACC neurons by physiological stimulation as well as pathological injury [2,14,15]. To determine if CREB activity contributes to neuronal survival in adult anterior cingulate neurons, we inhibited CREB activity by over-expressing pCMV-CREB133, a dominant negative CREB (mCREB), in the ACC of adult mice using a newly developed method of microelectroporation [16].

To determine if mCREB was actually expressed in cortical neurons, we first performed microelectroporation of the GFP tagged mCREB (GFP-mCREB) into the mouse ACC. Consistent with a previous study, which overexpressed a mutant form of calmodulin (CaM) in the ACC [16], cells transfected with GFP-mCREB were found in the area surrounding the injection site (n = 8 mice; Fig. 1A). Next, we wanted to determine if inhibiting CREB activity, by overexpressing mCREB, might affect the survival of cingulate neurons. In order to quantify the loss of cortical pyramidal cells, we used YFP transgenic mice that selectively express YFP in cortical pyramidal neurons [17]. Interestingly, the overexpression of mCREB led to a significant loss of pyramidal neurons in the ACC (n = 10 mice; Fig. 1B). YFP fluorescence was reduced at the transfected area (n = 10 mice; mean, 66%; ranging from 30% to 92% reduction). Since microelectroporation was performed on only one side of the ACC, a direct comparison of the effects of CREB could be made within the same animal. Experiments were also performed using the pCMV vector alone to determine if it had any effect in the absence of the expression of mCREB. No neurodegeneration was found in these animals (n = 5 mice). Additional staining experiments were performed to examine cytopathological features of apoptosis in degenerating cortical neurons that were transfected by mCREB. Hoechst nucleus staining showed that the nuclei had chromatin condensation, pyknosis, and fragmentation (n = 5 mice, Fig. 1C). Caspase 3 staining showed abundant caspase-3 positive cells at the mCREB transfection area, as compared to the wild-type mouse (n = 10 mice, Fig. 1C).

thumbnailFigure 1. Effects of overexpressing mutant CREB in adult cingulate neurons. a. Transfected ACC area showing GFP tagged mCREB protein expression. Scaled Bar: 10 μm. b. YFP mouse brain transfected with the CREB vector. The pCMV transfected brain showed no neurodegeneration (right). The mCREB transfected area showed significant neurodegeneration (left). c. Hoechst nucleus staining showed nuclear condensation and fragmentation at the mCREB transfected area (Top). Caspase 3 staining showed that apoptosis occurred at the mCREB transfected area (Lower).

Our results provide direct evidence that CREB activity plays a critical role in the survival of adult cingulate cortical neurons. The expression of mCREB induced significant apoptosis at the mCREB transfection area. The ability of mCREB to initiate programmed cell death in cortical neurons is consistent with CREB's role in survival and apoptosis described in in vitro studies [5-9]. Loss of neurons due to inhibition of CREB activity may provide a molecular mechanism for cellular loss in forebrain regions related to various mental illnesses. Furthermore, drugs targeted at the CREB signaling pathways may help to prevent or rescue neuronal loss in the brain.

Materials and methods

Surgical procedures were performed in sterile conditions and were approved by the Animal Care and Use committees of Washington University School of Medicine and the University of Toronto. For microelectroporation, a Grass SD9 stimulator was used to deliver square wave electric pulses. A pair of silver electrodes were placed 3 mm anterior and 2 mm posterior to the injection site, respectively (2.5 mm depth). The animals were placed in a Kopf stereotaxic apparatus fitted with a mouse adaptor. Microinjections of DNA into the ACC were performed at the following coordinates: 0.7 mm anterior to the Bregma, 0.4 mm to the midline, and 1.8 mm depth from the surface of the skull. The pCMV-CREB133 (0.8 μl) and pCMV vector DNA (0.5 μg/μL) were injected at each site at a rate of 0.05 μl/min, using a 30 gauge needle with cannula tubing connected to a Hamilton syringe. Adult YFP (yellow fluorescent protein) mice (n = 15 mice; 23–26 g, generously provided by Dr. Sanes [17]) were used. Ten YFP mice were microinjected with pCMV-CREB133, and 5 YFP mice were microinjected with pCMV vector. Wild-type (wt) pCMV-CREB vector and mutant CMV-CREB133 vector were purchased from Clontech (Cat 6014-1, BD Biosciences Clontech, Palo Alto, CA). The pCMV-CREB vector constitutively expresses the human wild-type (wt) CREB protein and the pCMV-CREB133 vector expresses a mutant variant of the human CREB protein that contains a serine to alanine mutation corresponding to amino acid 133. This mutation blocks the phosphorylation of CREB. The fusion of the GFP to the N-terminus of mCREB allowed us to determine the level of protein expression.

Acknowledgements

We thank Dr. Joshua Sanes for providing YFP mice. This work is supported by grants from the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health and Canadian Research Chair, and NIH NINDS NS42722 to M.Z.

References

  1. West AE, Chen WG, Dalva MB, Dolmetsch RE, Kornhauser JM, Shaywitz AJ, Takasu MA, Tao X, Greenberg ME: Calcium regulation of neuronal gene expression.

    Proc Natl Acad Sci USA 2001, 98(20):11024-11031. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  2. Silva AJ, Kogan JH, Frankland PW, Kida S: CREB and memory.

    Annu Rev Neurosci 1998, 21:127-148. PubMed Abstract | Publisher Full Text OpenURL

  3. Kandel ER: The molecular biology of memory storage: a dialogue between genes and synapses.

    Science 2001, 294(5544):1030-1038. PubMed Abstract | Publisher Full Text OpenURL

  4. Deisseroth K, Mermelstein PG, Xia H, Tsien RW: Signaling from synapse to nucleus: the logic behind the mechanisms.

    Curr Opin Neurobiol 2003, 13(3):354-365. PubMed Abstract | Publisher Full Text OpenURL

  5. Gonzalez GA, Montminy MR: Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133.

    Cell 1989, 59(4):675-680. PubMed Abstract | Publisher Full Text OpenURL

  6. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME: Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.

    Science 1999, 286(5443):1358-1362. PubMed Abstract | Publisher Full Text OpenURL

  7. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD: Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons.

    Science 1999, 286(5448):2358-2361. PubMed Abstract | Publisher Full Text OpenURL

  8. Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, Martin Villalba A, Tronche F, Kellendonk C, Gau D, Kapfhammer J, et al.: Disruption of CREB function in brain leads to neurodegeneration.

    Nat Genet 2002, 31(1):47-54. PubMed Abstract | Publisher Full Text OpenURL

  9. Dawson TM, Ginty DD: CREB family transcription factors inhibit neuronal suicide.

    Nat Med 2002, 8(5):450-451. PubMed Abstract | Publisher Full Text OpenURL

  10. Soderling TR: The Ca-calmodulin-dependent protein kinase cascade.

    Trends Biochem Sci 1999, 24(6):232-236. PubMed Abstract | Publisher Full Text OpenURL

  11. Devinsky O, Morrell MJ, Vogt BA: Contributions of anterior cingulate cortex to behaviour.

    Brain 1995, 118(1):279-306. PubMed Abstract OpenURL

  12. Vogt BA: Pain and emotion interactions in subregions of the cingulate gyrus.

    Nat Rev Neurosci 2005, 6(7):533-544. PubMed Abstract | Publisher Full Text OpenURL

  13. Sanders GS, Gallup GG, Heinsen H, Hof PR, Schmitz C: Cognitive deficits, schizophrenia, and the anterior cingulate cortex.

    Trends Cogn Sci 2002, 6(5):190-192. PubMed Abstract | Publisher Full Text OpenURL

  14. Wei F, Qiu CS, Liauw J, Robinson DA, Ho N, Chatila T, Zhuo M: Calcium calmodulin-dependent protein kinase IV is required for fear memory.

    Nat Neurosci 2002, 5(6):573-579. PubMed Abstract | Publisher Full Text OpenURL

  15. Wei F, Qiu CS, Kim SJ, Muglia L, Maas JW, Pineda VV, Xu HM, Chen ZF, Storm DR, Muglia LJ, et al.: Genetic elimination of behavioral sensitization in mice lacking calmodulin-stimulated adenylyl cyclases.

    Neuron 2002, 36(4):713-726. PubMed Abstract | Publisher Full Text OpenURL

  16. Wei F, Xia XM, Tang J, Ao H, Ko S, Liauw J, Qiu CS, Zhuo M: Calmodulin regulates synaptic plasticity in the anterior cingulate cortex and behavioral responses: a microelectroporation study in adult rodents.

    J Neurosci 2003, 23(23):8402-8409. PubMed Abstract | Publisher Full Text OpenURL

  17. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR: Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP.

    Neuron 2000, 28(1):41-51. PubMed Abstract | Publisher Full Text OpenURL